- Home
- SMXT vs SPRB Comparison
SMXT vs SPRB Comparison
Compare SMXT & SPRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMXT
- SPRB
- Stock Information
- Founded
- SMXT 2008
- SPRB 2014
- Country
- SMXT United States
- SPRB United States
- Employees
- SMXT N/A
- SPRB N/A
- Industry
- SMXT
- SPRB Medicinal Chemicals and Botanical Products
- Sector
- SMXT
- SPRB Health Care
- Exchange
- SMXT NYSE
- SPRB Nasdaq
- Market Cap
- SMXT 27.9M
- SPRB 22.8M
- IPO Year
- SMXT 2024
- SPRB 2020
- Fundamental
- Price
- SMXT $1.04
- SPRB $0.52
- Analyst Decision
- SMXT
- SPRB Hold
- Analyst Count
- SMXT 0
- SPRB 7
- Target Price
- SMXT N/A
- SPRB $2.50
- AVG Volume (30 Days)
- SMXT 119.8K
- SPRB 400.8K
- Earning Date
- SMXT 11-19-2024
- SPRB 11-11-2024
- Dividend Yield
- SMXT N/A
- SPRB N/A
- EPS Growth
- SMXT N/A
- SPRB N/A
- EPS
- SMXT N/A
- SPRB N/A
- Revenue
- SMXT $36,735,765.00
- SPRB $7,101,000.00
- Revenue This Year
- SMXT N/A
- SPRB N/A
- Revenue Next Year
- SMXT N/A
- SPRB N/A
- P/E Ratio
- SMXT N/A
- SPRB N/A
- Revenue Growth
- SMXT N/A
- SPRB N/A
- 52 Week Low
- SMXT $0.60
- SPRB $0.41
- 52 Week High
- SMXT $15.88
- SPRB $5.95
- Technical
- Relative Strength Index (RSI)
- SMXT N/A
- SPRB 47.26
- Support Level
- SMXT N/A
- SPRB $0.51
- Resistance Level
- SMXT N/A
- SPRB $0.56
- Average True Range (ATR)
- SMXT 0.00
- SPRB 0.03
- MACD
- SMXT 0.00
- SPRB -0.01
- Stochastic Oscillator
- SMXT 0.00
- SPRB 16.61
About SMXT SOLARMAX TECHNOLOGY INC
SolarMax Technology Inc is an integrated solar and renewable energy company. It operates in two segments namely the United States and China. The United States business includes the sale and installation of photovoltaic and battery backup systems. China operations consist of operating and maintaining solar farm projects and identifying and procuring solar farm projects for resale to third parties. Some of its products are LG Solar Panels, QCELL Solar Panels, Panasonic Solar Panels, and others. The company generates a majority of its revenue from the Solar energy systems.
About SPRB Spruce Biosciences Inc.
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).